Back to: Global IDMP Implementation – Getting Closer to the Goal
🔔 Note: Stop playback at 47:37 to complete this lesson.
Presenter
Olof Lagerlund, PhD
Substance Expert
Uppsala Monitoring Centre
WHO Collaborating Centre for International Drug Monitoring
Abstract
This presentation outlines the progress towards global IDMP implementation, a key initiative for standardizing medicinal product identification in healthcare. It focuses on the Pharmaceutical Product Identifier (PhPID), which comprises substance, strength, and dose form, and is crucial for enhanced safety, improved shortage management, cross-border healthcare, and system interoperability. The Global IDMP Working Group (GIDWG) conducts end-to-end testing, evaluating comparable products from various regions to harmonize divergent descriptions. Challenges include standardizing substance identifiers, managing strength unit expressions, and aligning diverse dose form terminologies, which the GIDWG addresses through specific business rules, conversion tables, and global dose form attributes. The group achieves high success rates in assigning substance and PhPIDs, even for complex cases. Important findings highlight the value of connecting PhPIDs with local product IDs for better data interpretation and the concept of an “overarching PhPID” to improve search functionalities. This work establishes a robust framework, fostering confidence in the global PhPID’s readiness for broad adoption.